Se habla español Offices in Orlando and Davenport, Florida [email protected]

Services

From the first evaluation of a swollen joint to long-term treatment and monitoring.

Written by Dr. Edgar A. Martorell, MD, rheumatologist Last updated Sources cited Editorial policy

Inflammatory arthritis

Diagnosis and long-term management of arthritis caused by an overactive immune system.

  • Early-arthritis evaluation for new joint swelling or prolonged morning stiffness
  • Rheumatoid arthritis, seropositive and seronegative
  • Psoriatic arthritis, including nail, skin and tendon involvement
  • Axial spondyloarthritis and ankylosing spondylitis
  • Treat-to-target care with regular disease-activity checks
  • Conventional DMARDs such as methotrexate, plus biologic and targeted therapies when needed

Lupus & autoimmune disease

Careful evaluation and monitoring of conditions that can affect many organs.

  • Systemic and cutaneous lupus
  • Sjögren's disease (dry eyes and dry mouth)
  • Vasculitis, including giant cell arteritis
  • Polymyalgia rheumatica
  • Scleroderma, myositis and Raynaud's phenomenon
  • Interpreting a positive ANA or other autoantibody test

Gout & crystal arthritis

Treating the flare today and preventing the next one.

  • Rapid treatment of gout flares
  • Joint aspiration to look for crystals under the microscope
  • Urate-lowering therapy dosed to a target uric acid level
  • Calcium pyrophosphate deposition (CPPD, "pseudogout")
  • Diet, alcohol and medication review that supports treatment

Bone & joint health

Keeping bones strong and joints working as you age.

  • Osteoarthritis of the knee, hip, hand and spine
  • Osteoporosis and osteopenia: bone density results, fracture-risk assessment and treatment
  • Bone protection for people taking long-term steroids
  • Bursitis, tendinitis and other soft-tissue problems
  • Fibromyalgia and widespread pain

Treatments and procedures in detail

Who each one is for, what happens, and what to expect afterward.

Early-arthritis evaluation

Who it's for
Adults with new joint swelling, morning stiffness lasting more than an hour, or a positive RF or anti-CCP test.
What happens
A detailed history and joint-by-joint exam, blood tests for inflammation and antibodies, and X-rays or ultrasound when they would change the plan.
Afterward
No downtime. Results are reviewed together at a follow-up visit.
Good to know
Rheumatoid arthritis guidelines advise starting disease-modifying treatment as soon as the diagnosis is made.

Joint aspiration & fluid analysis

Who it's for
A swollen joint where the cause is unclear, or suspected gout, pseudogout or infection.
What happens
After numbing the skin, a thin needle removes fluid from the joint. The fluid is checked for crystals, cell count and infection.
Afterward
Most people return to normal activity the same day. Removing fluid often relieves pressure and pain.
Good to know
Seeing crystals under the microscope is the most direct way to confirm gout.

Corticosteroid joint & soft-tissue injections

Who it's for
Flares of arthritis in one or a few joints, osteoarthritis of the knee or hip, and some cases of bursitis.
What happens
Medicine is injected directly into the joint or bursa. Ultrasound guidance may be used for deeper joints such as the hip.
Afterward
Rest the joint for a day or two. Relief often begins within days and can last weeks to months.
Good to know
Injections are usually limited in number per joint. Blood sugar may rise briefly in people with diabetes.

Disease-modifying therapy (DMARDs)

Who it's for
People with rheumatoid arthritis, psoriatic arthritis, lupus and related conditions.
What happens
Medicines such as methotrexate, hydroxychloroquine, sulfasalazine or leflunomide calm the immune system to control inflammation, not only pain.
Afterward
Regular blood tests check safety. Benefits build over weeks to a few months.
Good to know
Methotrexate is the recommended first-line DMARD for most people with moderate-to-high RA activity.

Biologic & targeted therapies

Who it's for
Inflammatory arthritis or autoimmune disease that hasn't reached its target on conventional treatment.
What happens
These medicines block specific immune signals such as TNF, IL-6, IL-17 or IL-23, or work through JAK pathways. Some are self-injected; others are given as an IV infusion.
Afterward
Before starting, screening usually includes tests for tuberculosis and hepatitis B and a vaccine review.
Good to know
Ask the office how and where infusion medicines are given for your plan.

Bone health & osteoporosis care

Who it's for
Women 65 and older, younger postmenopausal women with risk factors, people with a fracture after a minor fall, and people on long-term steroids.
What happens
Review of bone density (DXA) results and fracture risk, a check for causes of bone loss, then a plan that may include calcium, vitamin D, exercise and medication.
Afterward
Bone density is usually rechecked at intervals your doctor recommends.
Good to know
Treatment options include bisphosphonates, denosumab and bone-building medicines.

Which tests and treatments are available at each office, and how infusion medicines are arranged, can vary. Please confirm with the office when you book.

Treat-to-target, explained

For rheumatoid arthritis, guidelines recommend agreeing on a goal and adjusting treatment until it's reached. Gout care works the same way, with a uric acid target.

The aim for RA is remission or low disease activity. EULAR advises looking for meaningful improvement within about three months and reaching the target within about six.[1] Methotrexate is the recommended starting DMARD for most people with moderate-to-high activity.[2]

  1. Measure

    Count tender and swollen joints, check labs, ask how you're really doing.

  2. Compare

    Is disease activity at the agreed target: remission or low activity?

  3. Adjust

    If not, change the dose or the medicine rather than waiting.

  4. Recheck

    Review again in weeks to months, until the target is reached and held.

Common lab tests, decoded

What the letters on your lab report mean, and what they don't.

ANA
Antinuclear antibodies. Positive in nearly everyone with lupus, but also in up to 15% of healthy people.
RF
Rheumatoid factor. Found in many people with RA, but also in some healthy people and other conditions.
Anti-CCP
Antibodies to cyclic citrullinated peptides. More specific for rheumatoid arthritis than RF.
ESR & CRP
General markers of inflammation. Useful for tracking activity, but not specific to one disease.
Uric acid
Used to guide gout treatment. The usual target on urate-lowering therapy is below 6 mg/dL.
HLA-B27
A genetic marker linked to axial spondyloarthritis. Many people who carry it never develop the disease.
Complement & anti-dsDNA
Help track lupus activity, especially kidney involvement.
Urinalysis
Screens for kidney inflammation in lupus and vasculitis.

Sources: ACR ANA fact sheet[3], 2010 ACR/EULAR RA classification criteria[4], ACR 2020 gout guideline[5].

Sources

  1. Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3-18. doi:10.1136/ard-2022-223356 View source (opens in a new tab)
  2. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924-939. doi:10.1002/acr.24596 View source (opens in a new tab)
  3. American College of Rheumatology. Antinuclear Antibodies (ANA). Patient fact sheet, updated February 2025. View source (opens in a new tab)
  4. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-2581. doi:10.1002/art.27584 View source (opens in a new tab)
  5. FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020;72(6):744-760. doi:10.1002/acr.24180 View source (opens in a new tab)
  6. American College of Rheumatology. 2026 Update of the American College of Rheumatology Recommendations for the Management of Osteoarthritis of the Knee, Hip, and Hand: guideline summary (posted September 2026; full guideline forthcoming). View source (opens in a new tab)
  7. Gossec L, Kerschbaumer A, Ferreira RJO, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis. 2024;83(6):706-719. View source (opens in a new tab)
  8. LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049-2102. (Bone Health & Osteoporosis Foundation) View source (opens in a new tab)

Stiff, swollen or sore and not sure why?

Start with a conversation. Email the office and they'll reply with how to book in Orlando or Davenport. Se habla español.